Elicio Therapeutics Inc. (ELTX) financials · $132.3M cap
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Elicio Therapeutics Inc. (ELTX) $132.3M cap.
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Income | -$37.7M | -$45.0M |
| Net Income | -$39.6M | -$51.9M |
| EPS (Diluted) | -$2.58 | -$4.25 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $25.9M | $28.2M |
| Current Assets | $19.3M | $20.7M |
| Cash & Equivalents | $18.6M | $17.6M |
| PP&E | $295.0K | $483.0K |
| Total Liabilities | $24.2M | $39.5M |
| Current Liabilities | $8.11M | $11.5M |
| Long-term Debt | $9.41M | $20.0M |
| Total Debt | $9.41M† | $20.0M† |
| Shareholders' Equity | $1.64M | -$11.3M |
| Retained Earnings | -$233.7M | -$194.1M |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$37.0M | -$37.1M |
| CapEx | $16.0K | $87.0K |
| Investing Cash Flow | -$16.0K | -$84.0K |
| Financing Cash Flow | $36.7M | $42.3M |
| Net Change in Cash | -$225.0K | $5.19M |
| Free Cash Flow | -$37.0M | -$37.2M |
FAQ
What is ELTX P/E and revenue?
Elicio Therapeutics Inc. (ELTX) $132.3M cap.
What is ELTX revenue?
ELTX income-statement cache has no revenue figure yet.
Is ELTX profitable?
Elicio Therapeutics Inc. last cached net income is -$39.6M (FY2025).
What are ELTX total assets?
Elicio Therapeutics Inc. last cached total assets are $25.9M (FY2025).
What is ELTX free cash flow?
Elicio Therapeutics Inc. last cached free cash flow is -$37.0M (FY2025).
Not investment advice. Cached statements, not a live tape.